Alien Tarantula is a modern hybrid-indica cultivar developed through the crossbreeding of Alien Kush and Alien Technology. As a genetically focused variation within the Alien family, the strain reflects a targeted approach to hybridization that prioritizes consistent growth traits. It is suitable for cultivation in both indoor and outdoor environments, offering a high yield for growers who can manage its moderate flowering period of 60 days.

The terpene profile of Alien Tarantula is dominated by myrcene, which is supported by secondary notes of caryophyllene and a tertiary finish of pinene. This specific chemical composition defines the strain’s sensory experience, grounding its aroma and flavor profile in the interaction between these three distinct terpenes. The combination provides a structured aromatic output that directly stems from its inherited genetic lineage.

With a THC-dominant profile testing at approximately 20.8% and negligible CBD concentrations of 0.04%, Alien Tarantula is primarily sought for its ability to induce states of relaxation and focus. These effects make it a viable selection for users managing pain, stress, or sleep-related concerns. Currently, there are no notable offspring recorded for this strain, marking it as a distinct entry within the modern hybrid-indica classification.